drugset / Trial / NCT06277635

Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases

NCT06277635

RandomizedParallel-groupDouble-blindTreatment

Summary

To study the effect of silymarin against methotrexate-induced liver injury in rheumatic diseases including rheumatoid arthritis, psoriatric arthritis and psoriasis

Timeline

Start
2024-02-01
Primary completion
2025-04
Completion
2025-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Silymarin Traditional medicine (herbal / TCM) 140 mg Oral